The study for association between circulating angiopoetin like protein 2 (ANGPTL2) and various markers related to diabetes in patients with type 2 diabetes

The study for association between circulating angiopoetin like protein 2 (ANGPTL2) and various markers related to diabetes in patients with type 2 diabetes - Association between circulating ANGPTL2 and various markers related to DM in T2DM patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000025767

Enrollment

Registered

2017-01-22

Start date

2017-01-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) patients (male or femal) aged 20 or over at enrollment 2) patients diagnosed as type 2 diabetes (based on criteria in Japan Diabetes Society 2010) 3)Patients who are hospitalized for glycemic control for type 2 diabetes 4)patients giving consent in writing for participation for this study

Exclusion criteria

Exclusion criteria: 1)Patients with type 1 diabetes, pancreatic diabetes or secondary diabetes (Cushing syndrome, acromegaly etc.) diabetic coma or diabetic pre-coma, or type 1 diabetes 2)Patients under pregnancy, possible pregnancy, or lactation 3)Furthermore, patients judged as inadequacy for participation in this study by medical doctor

Design outcomes

Primary

Measure	Time frame
Association between ANGPTL2 and various markers related to type 2 diabetes or atherosclerosis or between ANGPTL2 and degrees of progression of diabetic complications (cross-sectional)	—

Countries

Japan

Contacts

Public ContactKohzo T Takebayashi

Dokkyo Medical University Koshigaya Hospital Internal Medicine (Diabetes, Endocrinology, Hematology)

takebaya@dokkyomed.ac.jp048-965-1111

Outcome results